Tumor Lysis Syndrome in Patients with Hematological Malignancies - PubMed (original) (raw)

Review

Tumor Lysis Syndrome in Patients with Hematological Malignancies

Yohannes Belay et al. J Oncol. 2017.

Abstract

Tumor lysis syndrome is a metabolic complication that may follow the initiation of cancer therapy. It commonly occurs in hematological malignant patients particularly non-Hodgkin's lymphoma and acute leukemia due to chemotherapy or spontaneously. It is characterized by a biochemical abnormality such as hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia and its clinical outcome is directly related to these biochemical abnormalities. Prevention and treatment of tumor lysis syndrome depend on immediate recognition of patients at risk. Therefore, identifying patients at risk and prophylactic measures are important to minimize the clinical consequences of tumor lysis syndrome. Patients with low risk should receive hydration and allopurinol. On the other hand patients with high risk should receive hydration and rasburicase in an inpatient setting. It is important to start therapy immediately, to correct all parameters before cancer treatment, to assess risk level of patients for TLS, and to select treatment options based on the risk level. In this review a comprehensive search of literatures was performed using MEDLINE/PubMed, Hinari, the Cochrane library, and Google Scholar to summarize diagnostic criteria, incidence, predicting factors, prevention, and treatment options for tumor lysis syndrome in patients with hematological malignancies.

PubMed Disclaimer

Similar articles

• Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase.
  Alakel N, Middeke JM, Schetelig J, Bornhäuser M. Alakel N, et al. Onco Targets Ther. 2017 Feb 2;10:597-605. doi: 10.2147/OTT.S103864. eCollection 2017. Onco Targets Ther. 2017. PMID: 28203093 Free PMC article. Review.
• Recombinant urate oxidase for prevention of hyperuricemia and tumor lysis syndrome in lymphoid malignancies.
  Ribeiro RC, Pui CH. Ribeiro RC, et al. Clin Lymphoma. 2003 Mar;3(4):225-32. doi: 10.3816/clm.2003.n.003. Clin Lymphoma. 2003. PMID: 12672271 Review.
• Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
  Baeksgaard L, Sørensen JB. Baeksgaard L, et al. Cancer Chemother Pharmacol. 2003 Mar;51(3):187-92. doi: 10.1007/s00280-002-0556-x. Epub 2003 Feb 28. Cancer Chemother Pharmacol. 2003. PMID: 12655435
• Rasburicase for the treatment of tumor lysis in hematological malignancies.
  Malaguarnera G, Giordano M, Malaguarnera M. Malaguarnera G, et al. Expert Rev Hematol. 2012 Feb;5(1):27-38. doi: 10.1586/ehm.11.73. Expert Rev Hematol. 2012. PMID: 22272702 Review.
• A Case Report of Newly Diagnosed Epithelial Ovarian Carcinoma Presenting with Spontaneous Tumor Lysis Syndrome and Its Successful Management with Rasburicase.
  Shukla DK, Gupta D, Aggarwal A, Kumar D. Shukla DK, et al. Indian J Med Paediatr Oncol. 2017 Jul-Sep;38(3):360-362. doi: 10.4103/ijmpo.ijmpo_23_16. Indian J Med Paediatr Oncol. 2017. PMID: 29200691 Free PMC article.

Cited by

• A rare case of spontaneous tumor lysis syndrome in multiple myeloma.
  Aldabain L, Camire L, Weisman DS. Aldabain L, et al. J Community Hosp Intern Med Perspect. 2020 Aug 2;10(4):365-368. doi: 10.1080/20009666.2020.1781748. J Community Hosp Intern Med Perspect. 2020. PMID: 32850100 Free PMC article.
• Laboratory and clinical features of tumor lysis syndrome in children with non-Hodgkin lymphoma and evaluation of long-term renal functions in survivors.
  Bozkurt S, Genc DB, Vural S. Bozkurt S, et al. BMC Pediatr. 2024 Jan 31;24(1):85. doi: 10.1186/s12887-024-04549-w. BMC Pediatr. 2024. PMID: 38297237 Free PMC article.
• Spontaneous Tumor Lysis Syndrome in a Patient with Bulky Chronic Lymphocytic Leukemia Diagnosed after Resolution of Symptoms.
  Menakuru SR, Priscu A, Khan I, Beirat A. Menakuru SR, et al. Case Rep Oncol. 2022 Apr 22;15(1):442-446. doi: 10.1159/000524198. eCollection 2022 Jan-Apr. Case Rep Oncol. 2022. PMID: 35702553 Free PMC article.
• Acute Liver Failure as the Leading Manifestation of Spontaneous Tumour Lysis Syndrome in a Patient with NonHodgkin Lymphoma: Do Current Diagnostic Criteria of Tumour Lysis Syndrome Need Re-Evaluation?
  Tarčuković J, Valenčić L, Polonijo Ž, Fućak A, Dangubić B, Grubješić I. Tarčuković J, et al. Case Rep Crit Care. 2019 Dec 26;2019:2358562. doi: 10.1155/2019/2358562. eCollection 2019. Case Rep Crit Care. 2019. PMID: 31949954 Free PMC article.
• Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma.
  Neelapu SS, Adkins S, Ansell SM, Brody J, Cairo MS, Friedberg JW, Kline JP, Levy R, Porter DL, van Besien K, Werner M, Bishop MR. Neelapu SS, et al. J Immunother Cancer. 2020 Dec;8(2):e001235. doi: 10.1136/jitc-2020-001235. J Immunother Cancer. 2020. PMID: 33361336 Free PMC article.

References

1. 1. Hande K. R., Garrow G. C. Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma. American Journal of Medicine. 1993;94(2):133–139. doi: 10.1016/0002-9343(93)90174-N. - DOI - PubMed
2. 1. Cairo M. S., Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. British Journal of Haematology. 2004;127(1):3–11. doi: 10.1111/j.1365-2141.2004.05094.x. - DOI - PubMed
3. 1. Ferlay J., Soerjomataram I., Dikshit R., et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. 2014 doi: 10.1002/ijc.29210. - DOI - PubMed
4. 1. Busakhala W., Joshi M. D., Abinya N. O., Amayo A., Abwao H. O. Incidence of chemotherapy-related tumour lysis syndrome at Kenyatta National Hospital, Nairobi. East African Medical Journal. 2007;84(3):100–109. - PubMed
5. 1. Konuma T., Ooi J., Takahashi S., et al. Fatal Acute tumor lysis syndrome following intrathecal chemotherapy for acute lymphoblastic leukemia with meningeal involvement. Internal Medicine. 2008;47(22):1987–1988. doi: 10.2169/internalmedicine.47.1456. - DOI - PubMed

Publication types

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Hindawi Limited
  • PubMed Central

• Other Literature Sources

  • scite Smart Citations